Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic and growth effects of two recombinant growth hormone treatment strategies in children born small for gestational age
2007-003850-26Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatropin in Short stature in children born small for gestational age (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Metabolic response and Growth response. Started Aug 2007; status: active.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on 2007-003850-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003850-26.